Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-11-01
|
| Series: | Journal of Neuroinflammation |
| Online Access: | https://doi.org/10.1186/s12974-023-02954-z |
| _version_ | 1797414447474540544 |
|---|---|
| author | Sam Gandy Michelle E. Ehrlich |
| author_facet | Sam Gandy Michelle E. Ehrlich |
| author_sort | Sam Gandy |
| collection | DOAJ |
| first_indexed | 2024-03-09T05:33:09Z |
| format | Article |
| id | doaj.art-5467600f5b4e41a2b7157765cabae1c5 |
| institution | Directory Open Access Journal |
| issn | 1742-2094 |
| language | English |
| last_indexed | 2024-03-09T05:33:09Z |
| publishDate | 2023-11-01 |
| publisher | BMC |
| record_format | Article |
| series | Journal of Neuroinflammation |
| spelling | doaj.art-5467600f5b4e41a2b7157765cabae1c52023-12-03T12:31:08ZengBMCJournal of Neuroinflammation1742-20942023-11-012011110.1186/s12974-023-02954-zCorrection: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathySam Gandy0Michelle E. Ehrlich1Department of Neurology, Icahn School of Medicine at Mount SinaiDepartment of Neurology, Icahn School of Medicine at Mount Sinaihttps://doi.org/10.1186/s12974-023-02954-z |
| spellingShingle | Sam Gandy Michelle E. Ehrlich Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy Journal of Neuroinflammation |
| title | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_full | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_fullStr | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_full_unstemmed | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_short | Correction: miR155, TREM2, INPP5D: Disease stage and cell-type are essential considerations when targeting clinical interventions based on mouse models of Alzheimer’s amyloidopathy |
| title_sort | correction mir155 trem2 inpp5d disease stage and cell type are essential considerations when targeting clinical interventions based on mouse models of alzheimer s amyloidopathy |
| url | https://doi.org/10.1186/s12974-023-02954-z |
| work_keys_str_mv | AT samgandy correctionmir155trem2inpp5ddiseasestageandcelltypeareessentialconsiderationswhentargetingclinicalinterventionsbasedonmousemodelsofalzheimersamyloidopathy AT michelleeehrlich correctionmir155trem2inpp5ddiseasestageandcelltypeareessentialconsiderationswhentargetingclinicalinterventionsbasedonmousemodelsofalzheimersamyloidopathy |